44 results about "Rna hybridization" patented technology

Compositions and methods for modulating the activity of RNA and DNA are disclosed. In accordance with preferred embodiments, antisense compositions are prepared comprising targeting and reactive portions. Reactive portions which act, alternatively, through phosphorodiester bond cleavage, through backbone sugar bond cleavage or through base modification are preferrably employed. Groups which improve the pharmacodynamic and pharmacokinetic properties of the oligonucleotides are also useful in accordance with certain embodiments of this invention. Delivery of the reactive or non-reactive functionalities into the minor groove formed by the hybridization of the composition with the target RNA is also preferrably accomplished. Therapeutics, diagnostics and research methods and also disclosed. Synthetic nucleosides and nucleoside fragments are also provided useful for elaboration of oligonucleotides and oligonucleotide analogs for such purposes.

The present invention describes methods for the characterization of mRNA molecules during mRNA production. Characterizing mRNA includes processes such as oligonucleotide mapping, reverse transcriptase sequencing, charge distribution analysis, and detection of RNA impurities. Oligonucleotide mapping includes using an RNase to digest antisense duplexes from an RNA transcript, and then subjecting the digested RNA to reverse phase HPLC, anion exchange HPLC, and/or mass spectrometry analysis. Reverse transcriptase sequencing involves reverse transcription of an RNA transcript followed by DNA sequencing. Charge distribution analysis can comprise procedures such as anion exchange HPLC, or capillary electrophoresis. Detection of impurities includes detecting short mRNA transcripts, RNA-RNA hybrids, and RNA-DNA hybrids.

The present invention relates to anti-heteronucleic acid antibodies and their uses for detection of RNA-DNA duplexes on arrays. The invention provides a method for detection of total cellular RNA hybridization on microarrays, thus obviating the need for isolation of the poly(A)+ fraction.

An apparatus and methods for electrostatic-based sensing and detection of charges and charged materials displayed on a surface. In a general embodiment, a method for electrostatically sensing charges or charged materials by comparing the electrostatic interaction between a capture surface and a reference surface. Assays to detect binding or interactions between a capture surface and a material to be detected are also described. We also describe a sensitive and label-free electrostatic readout of DNA or RNA hybridization in a microarray format and using a microfluidic device. The electrostatic properties of the hybridized particles are measured using the positions and motions of charged microspheres. This approach enables sensitive, non-destructive electrostatic imaging. Changes in surface charge density as a result of specific molecular interaction can be detected and quantified with great sensitivity, and in the presence of a complex background.

The present invention provides novel compositions and methods for suppressing the expression of a targeted gene using RNA-DNA hybrid constructs. The invention further provides novel methods and compositions for generating or producing RNA-DNA hybrids, whose quantity is high enough to be used for the invention's gene silencing transfection and possibly in therapeutics applications. This improved RNA-polymerase chain reaction method utilizes thermocycling steps of promoter-linked DNA or RNA template synthesis, in vitro transcription and then reverse transcription to bring up the amount of RNA-DNA hybrids up to two thousand folds within one round of the above procedure for specific gene silencing.

This invention is related to the use of at least one oligonucleotide with a length of from about 8 to about 30 nucleotide building blocks for manufacturing a pharmaceutical preparation for the prophylaxis and/or the treatment of diseases, that are modulated by TGF-beta2, TGF-beta1, TGF-beta3, VEGF, interleukin-10, c-jun, c-fos, and/or prostaglandin E2 in a mammal, wherein said oligonucleotide hybridizes with a messenger RNA of a TGF-beta2, TGF-beta1, TGF-beta3, VEGF, interleukin-10, c-jun, c-fos and/or prostaglandin E2 gene and wherein said preparation comprises said oligonucleotide in a concentration of about 1 microM to about 25 microM.

The present invention provides, inter alia, methods of selecting a single-stranded oligomeric compounds for inhibiting RNA expression, methods of generating double-stranded oligomeric compounds, methods of identifying optimized double-stranded oligomeric compounds, methods of selecting optimized single-stranded oligomeric compounds, methods of selecting optimized double-stranded oligomeric compounds, methods of identifying multifunctional oligomeric compounds, methods for optimizing target region selection for modulation of RNA expression, methods of optimizing expression modulation of RNA, and the like. The present invention further provides oligomeric compounds, 8-80 nucleobases in length targeted to a target RNA, wherein said oligomeric compound hybridizes to said target RNA and inhibits RNA levels by at least 50% in both single-stranded and double-stranded forms, and multifunctional oligomeric compounds.

Methods for determining the presence, absence and/or amount and/or identity of RNA in a biological or other sample employs capturing and separating a DNA:RNA hybrid formed by a DNA probe and the RNA of interest from unhybridized DNA and RNA with an RNase H under conditions wherein the nuclease activity of the RNase H is inhibited, releasing the DNA probe by altering the conditions so that the nuclease activity is restored, and determining the presence or amount, and, for multiplex samples, nature of the DNA released. The method can be used to determine RNA of various types, including RNA comprising transcriptomes.

The invention discloses an RNA quantitative detection method using the cutting single strand nucleic acid characteristic of S1 enzyme. The method mainly comprises the following steps: first, fixing a capture probe with proper concentration to a enzyme label plate precoated by the streptavidin for further use; then ultrasonically lysising the cell and releasing RNA from the cell, filling in signal probe and hybridizing with targeting RNA; after hybridizing, filling in S1 enzyme to cut the single strand part in the single RNA,DNA and RNA/signal probe crossbreed, obtaining the complete complementary targeting RNA/signal probe crossbreed; hybridizing between the capture probe and the signal probe after the rest crossbreed is denaturated, finally amplifying the signal by horseradish peroxidase. The invention has simple operation and strong specificity. The RNA quantitative detection can be finished under conventional experimental conditions.

The present invention discloses a tropical plant polysaccharide and polyphenol small RNA extraction method, which comprises: sampling tropical plant leaves, freezing in liquid nitrogen, and storing at a temperature of -80 DEG C; preparing small RNA extraction reagents, wherein the reagents comprise a CTAB lysis buffer solution, a PEG8000 precipitation buffer solution, an EDC cross-linking buffer solution, a miRNA Northern blotting hybridization buffer solution, 7% dPAGE, and Washing Buffer; according to small RNA extraction pretreatment, Trizol extraction, fractional precipitation of high molecular weight RNA, and small RNA precipitation, extracting small RNA; according to 17% dPAGE separation, trarsmembrane and cross-linking, miRNA hybridization and washing of membrane, small RNA hybridization and washing of membrane, and exposure and storage, achieving RNA hybridization; carrying out miRNA stem-loop RT-PCR amplification; and carrying out extraction and detection analysis on polysaccharide and polyphenol plant small RNA. According to the present invention, the defects in the current plant small RNA extraction method are overcome, characteristics of fastness, stability and easy operation are provided, rapid extraction and detection analysis can be performed on miRNA and siRNA, and broad application prospects are provided.

An isolated oligonucleotide comprising ribonucleotides is disclosed. The oligonucleotide comprises a nucleic acid sequence which encodes at least one copy of a splicing-factor binding site. The oligonucleotide is no more than 150 bases and may be devoid of a sequence that allows hybridization thereof to cellular RNA under physiological conditions. The oligonucleotide inhibits overall cellular splicing activity of a specific splicing factor. Pharmaceutical compositions comprising the oligonucleotide and uses thereof are further disclosed.

The invention relates to a probe set for detecting a small RNA and a method for detecting the small RNA by using the same and belongs to the field of small RNA detection. The DNA probe set for detecting the small RNA of the invention comprises at least two probes, wherein a segment of nucleotide sequence containing all connections of the connected at least two probes is complementary to the nucleotide sequence of a target small RNA molecular. The method for detecting the small RNA of the invention comprises the following steps: making the probes and the target small RNA first crossed and then connected under the action of a ligase; and finally, detecting the target small RNA by gel electrophoresis, real-time polymerase chain reaction and the like. The method for detecting the small RNA of the invention has the advantages of high sensitivity, large dynamic range, strong anti-interface capacity, low price and the like, and has wide application prospects in various fields related to small RNA detection, such as scientific experiments and clinical diagnosis.

The invention discloses a 'system displacement polymerase lymerase chain reaction', which is characterized by the following: displacing program PCR system with above one indicating PCR system; setting the each indicating PCR system augment as small part crossing sequence of independence indicator board and program mold; possessing non-homologous sequence in indicator board with program mold; inverting the program specimen PCR to about ten non-interference indicated PCR system; changing to another system when polluted; avoiding twice pollution of PCR product; crossing the indicated DNA with program DNA; or crossing with program RNA; augmenting directly; fitting for direct test of RNA specimen; co-using with fluorescence molecular beacon (Molecular beacon); fitting for quantitative determination of the program mold.

This application pertains to construction of pooled biological material such as DNA, RNA, proteins and the like that are able to be screened by a wide variety of methods such as PCR (Polymerase Chain Reaction), DNA/DNA hybridization, DNA/RNA hybridization, RNA/RNA hybridization, single strand DNA probing, protein/protein hybridization and a wide variety of additional methods. Our new method for construction of pools and superpools for screening differs in that the complete set is systematically divided into a variety of smaller subsets which are then re-pooled to make the final screening pools. This pooled material can be from individual samples or a population of samples. In order to reduce the analysis time, materials and expense, the pooling of high resolution small pools in a matrix allows for a lower number of user experiments to have higher resolution (as if the researcher had analyzed the complete set of small pools).

The invention relates to a kit and a method for determining the sequence and/or quantity of a ribonucleic acid in a composition, comprising the steps of: . i. providing a composition comprising one or more ribonucleic acids molecules (RNA), . ii. hybridizing to said one or more RNAs, one or more two-part nucleic acid hybridization probes, wherein each probe comprises, . a. a first nucleic acid molecule with a 3'-tail wherein said tail does not hybridize to an RNA in the composition, . b. a second nucleic acid molecule with a 5'-tail wherein said tail does not hybridize to an RNA in the composition, . c. wherein said first and said second nucleic acid molecules when and if hybridized to their target RNA lie on one single stranded RNA molecule separated from each other by between 2 and 1000 nucleotides, . iii. covalently linking the hybridized 5'-tail of said first nucleic acid molecule to the hybridized 3'-tail of said second nucleic acid, wherein the linking is done by means of reverse transcription and subsequent ligation, . binding the RNA-DNA hybrids to duplex-specific antibodies, . iv. amplifying the linked molecules with primers that are specific for said first 3'-tail of said first nucleic acid molecule and said second 5'-tail of said second nucleic acid molecule and, . v. sequencing the amplification products by means of next generation sequencing. . The kit comprises primers, antibodies and ligase or reverse transcriptase.

The invention provides a RNA one-step-lysis and one-tube RT-PCR (one-Step-lysis and One-tube RT-PCR, SORT-PCR) detection method. Compared to the conventional RT-PCR method, the RNA one-step-lysis and one-tube RT-PCR method does not need to purify and extract RNA, RNA is hybridly combined to a fixed specific primer or Oligo primer after cell lysis, other components in the cell lysis solution supernatant are washed away, then the RNA is added into a RT reaction system to perform RT reactions. After being dried again, the RNA is added into a PCR reaction system to perform PCR reactions, and the result can be detected by the fluorescence real-time quantitative analyzing method. The RNA one-step-lysis and one-tube RT-PCR detection method shortens the RNA detection process of more than 3 hours to 2 hours, and has the advantages of simple operation, high detection sensitivity and specificity, and suitability for detecting RNA from various sources of sample lysis.

The present invention relates to a method of identifying a gene encoding a polypeptide or polypeptide isoform which is substantially more active in either a proanthocyanidin (PA) or anthocyanin (ANT) pathway of a plant, said method including providing material from said plant; and an oligonucleotide probe capable of hybridizing with RNA from a gene encoding a polypeptide which is active in a flavonoid biosynthetic pathway; extracting RNA from said plant material; hybridizing the oligonucleotide probe with the RNA to generate an expression profile; measuring PA and/or ANT levels in said plant material to generate a metabolic profile; comparing said expression profile with said metabolite profile to identify said gene encoding a polypeptide or polypeptide isoform which is substantially active in either a PA or ANT pathway.

The present invention is directed to novel DNA-RNA hybrids comprising either a DNA sense strand and an RNA antisense strand, or an RNA sense strand and a DNA antisense strand. The compounds of the invention, and compositions and arrays comprising the same, may be used for a variety of purposes, including inhibiting gene expression, treating disease and infection, determining the function of genes, and identifying and validating novel drugs and their targets.

A biosensor platform apparatus and method are provided that can detect, purify and identify nucleic acid (DNA and RNA) biomarkers in complex biological fluids. The methods use a two-stage molecular based approach. The first stage screens for specific nucleic acid-based biomarkers in complex biological fluids by electrochemical detection of DNA:RNA hybridization and facilitates the removal of remaining complex media constituents. The first stage utilizes probes within a tunable nanoporous electrode. The second stage identifies the purified specific hybrids by single-molecule conductance measurements via break junction scanning. Identification can be assisted with a library of conductance measurements. The methods can provide strain level information that can be used for identifying anti-microbial resistance in detected pathogens. Collection of RNA targets allows for biomarker detection and identification without the need for amplification and can provide information about the viability of the sample organism.